Imetelstat
Geron Corporation
['gyn', 'mds']
phase 3 findings demonstrate durable benefit with imetelstat for patients with r/r mds #oncologynursing #asco23 #mds 
Capturing the voice of nursing professionals in the oncology news landscape.